Neurology

Your daily dose of clinical news you may have missed.

Screening for stress among older adults who present to primary care with signs of cognitive impairment could be key to reducing risk and targeting intervention, study authors say.

Standing at the kitchen sink, the patient experienced vertigo and near syncope. His vital signs are normal save a discrepancy in SBP between arms. What's your diagnosis?

Zavegepant, the first FDA-approved intranasal CGRP receptor antagonist, could be available in pharmacies by July 2023.

About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.

The prescription remote electrical neuromodulation device is now cleared for both acute and preventive treatment of migraine in those aged ≥12 years, according to Theranica.

Rebekah Bernard, MD, family physician and national speaker on physician wellness shares 3 pieces of advice on connecting with colleagues again.

ACC 2023. A large study found increased risk for MI regardless of age and detected particularly heightened risk among women and persons with diabetes who have insomnia.

The association between air pollution and Parkinson disease was found strongest in the Rocky Mountain region and the Mississippi-Ohio River Valley in a new study.

Even after mild cases of COVID-19, imaging found evidence of tissue atrophy and aberrant connectivity in persons with long-COVID-related anxiety, depression.

Find key takeaways from the US Centers for Disease Control and Prevention's latest Youth Risk Behavior Survey in our new slideshow.

Rebekah Bernard, MD, family physician and national speaker on physician wellness shares how physicians can recognize and help a colleague in emotional distress.

Your daily dose of clinical news you may have missed.

The large biobank-based study found 22 pairings of a neurodegenerative disorder and a previous viral infection. Vaccines exist against several of those viruses.

Pain relief from the intranasally-delivered calcitonin gene-related peptide antagonist began as soon as 15 minutes post-dose and for some patients lasted up to 48 hours.

The magnitude of the association with age did not change, however, for other stroke risk factors, including smoking, atrial fibrillation, and LVH, investigators report.

Primary care is increasingly the setting for mental health discussions, diagnosis, and treatment, underscoring the need for both structural and process change.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

Your daily dose of clinical news you may have missed.

Which states have the most residents reporting long COVID symptoms? Which ones have the least? Scroll through our new slideshow for answers.

Reductions in depressive symptoms were greater in adolescents aged ≥13 years and in those with a mental illness and/or depression diagnosis, according to systematic review and meta-analysis.

The novel oral agent is administered once daily for 14 days and has demonstrated rapid and sustained improvement in symptoms across trials.

Your daily dose of clinical news you may have missed.

Study participants with medication overuse headache reported quality of life improvements as early as study week 4 that were sustained at week 24.

How many Americans report having long COVID symptoms? Which demographics is long COVID more prevalent in? A new analysis sheds light.